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Background
Stromal derived factor (SDF-1) is a natural ligand for
CXCR4 and chemokine (C-C) motif ligand 3-like 1
(CCL3L1) is for CCR5 HIV coreceptors. The individual
role of the SNP in 3′ untranslated region of SDF-1
(SDF1-3′A) and low copy number of the CCL3L1 gene
in determining susceptibility to HIV infection is well
documented. The aim of the present study was to ana-
lyze the synergistic effect of the SNP in SDF-1 gene and
CNV in CCL3L1 gene influencing the susceptibility to
HIV-1/AIDS in Indians.
Methods
This study involved the assessment of 105 healthy con-
trol individuals and 44 HIV-1 patients for the SDF-1
gene polymorphism by PCR-restriction fragment length
polymorphism (RFLP) and CCL3L1 gene copy number
(CN) by real-time PCR.
Results
In order to assess the synergistic effect of the SDF1-3′A
polymorphism and CCL3L1 CN, SDF1-3′A allele and
CCL3L1 > 2 copies conferring a protection to HIV-1
were considered as reference combination. The odds
ratio (OR) was 0.97 (95% CI - 0.30 to 3.13; p = 0.597)
for SDF1-3′A, CCL3L1 < 2 copies, 0.73 (95% CI - 0.23
to 2.33; p = 0.408) for SDF1, CCL3L1 > 2 copies and
0.93 (95% CI - 0.327 to 2.703; p = 0.555) for SDF1-3′A,
CCL3L1 < 2 copies combinations as compared to SDF1-
3′A, CCL3L1 > 2 copies.
Conclusion
Our analyses suggest that a combination of SDF1-3′A
and lower copy number of CCL3L1 do not provide any
discernible synergistic protection from HIV-1 infection.
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